Rajya Sabha Is A Relic Of The Past
Indian Economy & Market|August 2017

Probably the first time the loud mouthed Samajwadi Party leader and Member of Parliament Naresh Agarwal raised an important issue in the Rajya Sabha when he attacked cricketer Sachin Tendulkar and actor Rekha, asking them to resign if they are not interested in the Parliament.

Krishna Kumar Mishra
Rajya Sabha Is A Relic Of The Past

He questioned the Chair that why shouldn’t their membership be canceled from the House. Records show that while the national average attendance of an MP is 78%, Sachin Tendulkar’s average as an MP is 7% and Rekha’s average stands at 5%. It would be conducive to compare it to the average attendance of other ten nominations. Sambhaji Raje with 100%, tops the list, whereas Subramanian Swamy is close second with 92%. All other nominations have a record attendance above 60%.

Prior to Sachin Tendulkar and Rekha, several other nominated members have recorded poor attendance in Parliament sessions. Lata Mangeshkar was a Rajya Sabha MP from November 1999 to 2005, and she attended merely six out of over 170 meetings. She used her power as an MP only to express discontent towards the possibility of a flyover being built opposite her house on Peddar Road, Mumbai. When asked about her lack of interest in attending Parliament sittings, she claimed that she had in fact pleaded with those who urged her into the Rajya Sabha to let her off; but then why did she accept the offer.

Rajya Sabha has equal powers to the Lok Sabha except for money bills, where it has no jurisdiction. It is a 250-member body, 238 are elected by an electoral college made up of state legislators. As per the Constitution Of India’s Fourth Schedule Articles 4 (1) and 80 (2), the President nominates 12 achievers to be a part of the Rajya Sabha for a term of six years for their outstanding contribution to art, literature, science and social services. But the nominations have always attracted controversy; the criteria are too vague. What has been observed over the last 70 years is a simple one liner funda - that to qualify one has to be sympathetic towards the party in power, have to be in their good books.

But this is one aspect only to start the arguments against the very usefulness of Rajya Sabha.

This story is from the August 2017 edition of Indian Economy & Market.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the August 2017 edition of Indian Economy & Market.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MORE STORIES FROM INDIAN ECONOMY & MARKETView All
WORLD DEVELOPMENT REPORT 2024 THE MIDDLE-INCOME TRAP
Indian Economy & Market

WORLD DEVELOPMENT REPORT 2024 THE MIDDLE-INCOME TRAP

A World Bank report titled 'World Development Report 2024: The Middle-Income Trap' indicates that India may take up to 75 years to attain just a quarter of the United States' per capita income. The insights in the report provides a useful reality check for India's ambitious goals, such as becoming a developed economy by 2047 or reaching a $5 trillion economy within the next three years.

time-read
5 mins  |
November 2024
IN CONVERSATION: "We are working with a Vision 2035. I'm sure within next 5 years we will be ranking among the Fortune 500 companies.”
Indian Economy & Market

IN CONVERSATION: "We are working with a Vision 2035. I'm sure within next 5 years we will be ranking among the Fortune 500 companies.”

Sudarshan Pharma Industries Ltd., led by its promoters, Mr. Hemal V. Mehta, a chemical engineer, and Mr. Sachin V. Mehta, has established a strong foundation in specialty chemicals and bulk drugs. Their relentless enthusiasm is visible when they speak. Indian Economy & Market reached out, to piece together the company's achievements and new initiatives in detail.

time-read
9 mins  |
November 2024
Sudarshan Pharma Industries Ltd. A MULTIBAGGER IN MAKING
Indian Economy & Market

Sudarshan Pharma Industries Ltd. A MULTIBAGGER IN MAKING

Sudarshan Pharma Industries Ltd. operates across various sectors in both the pharmaceutical and chemical industries, with a focus on specialty chemicals and intermediates, which find applications in Indian Le pharmaceuticals, paints, food products, and adhesives.

time-read
3 mins  |
November 2024
MUTUAL FUND LITE OR MF LIT PROMISING PROGRESS FOR INVESTORS
Indian Economy & Market

MUTUAL FUND LITE OR MF LIT PROMISING PROGRESS FOR INVESTORS

The SEBI has streamlined rules for passively managed schemes to have the impact of letting more players in the mutual fund ecosystem and offering diversified, low-risk investment options to retail investors. It would increase market liquidity and attract participation from old as well as new Asset Management Companies (AMCs). Shivanand Pandit feels that MF Lite is going to democratize investment opportunities in the Indian financial market.

time-read
5 mins  |
November 2024
GLOBALISM, FREEDOM & DEMOCRACY DO NOT MIX
Indian Economy & Market

GLOBALISM, FREEDOM & DEMOCRACY DO NOT MIX

The world today is packed with wealthy institutions and individuals that stand in revolt against the ideas of freedom and democracy. They do not like the idea of geographically constrained states with zones of juridical power.

time-read
6 mins  |
November 2024
BRICS Member States Ready to Dethrone Dollar
Indian Economy & Market

BRICS Member States Ready to Dethrone Dollar

AS the US weaponises the dollar in the Russian and Iranian sanctions, there is increasing desire by other developing countries to seek alternative currencies for trade, investment, and reserves, as well as developing alternative multilateral clearance systems outside of SWIFT.

time-read
3 mins  |
November 2024
7 BEST PHARMA COMPANIES
Indian Economy & Market

7 BEST PHARMA COMPANIES

The pharmaceutical industry in India is expected to reach $65 Bn by end of 2024 and to $130 Bn by 2030. India is a major exporter of Pharmaceuticals, with over 200+ countries served by Indian pharma exports. While Nifty's performance has been lackluster over the past month, several pharmaceutical stocks have shown resilience.

time-read
10+ mins  |
November 2024
NEW INVESTMENT PRODUCT CATEGORY IS SEBI'S LATEST MOVE COMMENDABLE?
Indian Economy & Market

NEW INVESTMENT PRODUCT CATEGORY IS SEBI'S LATEST MOVE COMMENDABLE?

The Securities and Exchange Board of India (SEBI) has introduced a consultation paper proposing a new investment product category aimed at addressing a specific market need. This proposed asset class would offer investment options that sit between mutual funds (MFS) and PMS, filling a gap and providing greater flexibility in portfolio management. The new investment vehicle is designed for investors who are prepared to take on riskier market positions but find PMS schemes or AIFs out of reach. SEBI after reviewing the feedback and finalizing the regulations through stakeholder discussions, may issue the final regulations.

time-read
5 mins  |
August 2024
DECODING THE CHINA MYTH
Indian Economy & Market

DECODING THE CHINA MYTH

Myths die hard. Among these is the great myth that China's poised to take over the world. Here, James Rickards debunks that myth.

time-read
7 mins  |
August 2024
What Is In Store For The Indian Economy?
Indian Economy & Market

What Is In Store For The Indian Economy?

Until the 2014 Lok Sabha elections, when the Bharatiya Janata Party secured 282 seats and Narendra Modi ascended to power, India experienced 21 years of coalition governments. A decade later, the BJP holds 240 seats in the Lok Sabha, and India is once again governed by a coalition. Fitch has indicated that coalition politics and a weakened mandate for the NDA could hinder the passage of ambitious reform legislation. It raises the question: Do coalition governments impede the economic reform agenda?

time-read
5 mins  |
July 2024